Massimiliana Landini Aleotti inherited the Menarini pharmaceutical fortune with her children after the death of her husband Alberto Aleotti, who had built and acquired the business over decades. [1]
The operating fortune was built before she inherited it
Forbes says Massimiliana Landini Aleotti and her children inherited Menarini after Alberto Aleotti died in 2014. Alberto had joined the drug company in 1964 and bought it from its owners in the early 1990s. [1]
By the time of succession, Menarini had already become one of Italy's major pharmaceutical groups, with a large international manufacturing footprint and thousands of employees. [1]
Forbes also notes that operational leadership had already shifted to the next generation before Alberto's death, with daughter Lucia serving as chairman and son Alberto Giovanni as vice chairman. [1]
Her wealth reflects family ownership more than operating control
The reviewed record establishes Massimiliana as a family owner of Menarini but does not document a comparable executive role in building or materially expanding the pharmaceutical group herself. [1]
Her billionaire wealth is therefore predominantly inherited through her spouse and family ownership. The evidence supports some stewardship as a family owner, but not enough direct operating contribution to treat the fortune as materially self-created. [1]
Sources for background
Sources reviewed Sep 25, 2026.
- Massimiliana Landini Aleotti & family · Forbes · Mar 10, 2026
Comparable Healthcare billionaires
Similar Healthcare billionaires by estimated net worth.
%2038%20crop.jpg?width=512)
